This inventor holds 7 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignee: Alpha Tau Medical Ltd.. Active years: 2022-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2025
Title: The Innovative Contributions of Michael Schmidt
Introduction
Michael Schmidt is a notable inventor based in Kfar Saba, Israel. He has made significant contributions to the field of radiotherapy, holding a total of seven patents. His work focuses on enhancing the effectiveness of cancer treatment through innovative methods involving radioactive materials.
Latest Patents
Among his latest patents is a method for the wet preparation of radiotherapy sources. This method involves accumulating radium radionuclides by providing a first solution that includes thorium radionuclides and a thorium-binding extractant. The first solution does not bind to radium, allowing a portion of the thorium radionuclides to decay into radium atoms. The collected radium atoms can then be included in a solution where brachytherapy sources are dipped, effectively collecting the radium atoms onto the source. Another significant patent is for diffusing alpha-emitter radiation therapy with enhanced beta treatment. This invention features an interstitial source suitable for implanting in a tumor, which includes radioactive atoms of one or more isotopes attached to a base. The radioactive atoms have a radon release rate of at least 0.5 micro-Curie (μCi) per centimeter length, emitting beta radiation that achieves an asymptotic dose of at least 10 Gy at a distance of 2 millimeters from the base.
Career Highlights
Michael Schmidt is currently associated with Alpha Tau Medical Ltd., a company dedicated to advancing cancer treatment technologies. His innovative approaches have positioned him as a key figure in the development of new therapeutic methods.
Collaborations
He has collaborated with notable colleagues such as Itzhak Kelson and Yona Keisari, contributing to the advancement of radiotherapy techniques.
Conclusion
Michael Schmidt's work exemplifies the intersection of innovation and healthcare, particularly in the field of cancer treatment. His patents reflect a commitment to improving patient outcomes through advanced radiotherapy methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile